Home / Import refusals / AEK-0407174-1/20002/1

FDA Import Refusal AEK-0407174-1/20002/1 — Novo Nordisk

Novo Nordisk — FEI 3009256540

The FDA refused shipment AEK-0407174-1/20002/1 from Novo Nordisk (India) on June 3, 2026. The refused product falls under Drugs and Biologics — AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
June 3, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
62OCY14 AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
Charges
75

Other import refusals

  • AEK-0725103-5/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4157426-0/10002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5519360-0/10001/1 (Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0407174-1/10002/1 (Wed Jun 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0070056-6/20003/1 (Wed May 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources